Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.14 USD
Change Today +0.04 / 1.90%
Volume 1.6M
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert F. Apple

Chief Operating Officer and Executive Vice President, Antares Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 3 different industries.

See Board Relationships
47$791,455
As of Fiscal Year 2014

Background*

Mr. Robert F. Apple, also known as Bob, has been Chief Operating Officer of Antares Pharma Inc. since September 15, 2014 and has been its Executive Vice President since July 2009. Mr. Apple has been President of the Parenteral Products Division of Antares Pharma Inc. since July 2009 and served as its Chief Financial Officer since February 09, 2006, Chief Accounting Officer and Secretary since February 9, 2006 and also served as its Principal Accounting Officer. He was ...

Read Full Background

Corporate Headquarters*

100 Princeton South
Ewing, New Jersey 08628

United States

Phone: 609-359-3020
Fax: --

Board Members Memberships*

2003-Present
Director

Education*

BA
Temple University

Other Affiliations*

Annual Compensation*

Salary$391,084
Total Annual Compensation$391,084

Stock Options*

Restricted Stock Awards$290,290
All Other Compensation$10,064
Exercised Options10,000
Exercised Options Value$45,300
Exercisable Options1,069,556
Exercisable Options Value$1,145,670
Unexercisable Options100,426
Total Value of Options$1,190,970
Total Number of Options1,179,982

Total Compensation*

Total Annual Cash Compensation$401,148
Total Short Term Compensation$391,084
Other Long Term Compensation$300,354
Total Calculated Compensation$791,455
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $2.14 USD +0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William M. Greenman Chief Executive Officer, President and Director
Cerus Corporation
$520.8K
Caren L. Mason Chief Executive Officer, President, Director and Chairman of Quality & Regulatory Committee
STAAR Surgical Company
--
Jeffrey M. Nugent Chief Executive Officer, President, Director and Member of Finance Committee
BIOLASE, Inc.
$150.0K
Gary R. Maharaj Chief Executive Officer, President and Director
SurModics, Inc.
$443.7K
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.